Filing Flows

Filing Flows › agilon health (AGL) › Q2 2025

agilon health (AGL) Q2 2025 earnings results (second quarter 2025)

10-Q filed Aug 4, 2025

agilon health (AGL) reported revenue of $1.4B for the second quarter 2025 (Q2 2025), -6% from a year earlier and -9% from the quarter before. Operating margin was -8.3%, net loss $104M (7.5% of revenue).

Revenue$1.4B
Year over year-6%
Quarter over quarter-9%
Operating margin-8.3%
Net earnings−$104M

agilon health, Q2 2025: revenue $1.4B (-6% year over year), operating margin -8.3%, net loss $104M, operating cash flow −$35.1M. The chart follows the revenue to costs, profit and cash.

Q2 2025AmountQ/QY/Y
Revenue$1.4B-9%-6%
Operating profit−$116M——
Net earnings−$104M-962%—
Operating cash flow−$35.1M——

What changed

Revenue was $1.4B in Q2 2025, down 6% year over year and down 9% from the previous quarter. Medical services revenue was the largest line at 100% of revenue. Medical services revenue lost $0.09B year over year (down 6%), 100% of the total change.

Operating costs exceeded revenue by $0.12B, an operating margin of -8.3%. Total costs fell 1% while revenue fell 6%. The quarter ended with a net loss of $0.10B, after a profit of $0.01B the previous quarter.

Operating cash flow was −$0.04B. Non-cash charges added back $0.01B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items added $0.05B. Capital expenditures of $3.2M exceeded it, leaving free cash flow of −$0.04B.

Questions

What was agilon health's revenue in the second quarter 2025?

agilon health (AGL) reported revenue of $1.4B for the second quarter 2025 (Q2 2025), -6% from a year earlier and -9% from the quarter before.

Was agilon health profitable in the second quarter 2025?

Operating loss was $116M (-8.3% of revenue) and net loss $104M.

Open the interactive Sankey →

Source: agilon health 10-Q on SEC EDGAR.